The verified answer
As of Aug 2026, DEPLOY verifies CMR Surgical: 1 model, 2 deployments across 2 regions, 5 active incidents. 9 sources back the record.
CMR Surgical holds 2 FDA De Novo authorizations, per the DEPLOY registry.
See all 2 filingsCategorySurgical robots
Deploy Watch
Track CMR Surgical on Deploy.
We notify you when a verified state change lands on the record, not when the company issues a claim.
Regional ecosystem
CMR Surgical is one of 84 verified robotics companies in the United Kingdom →
Key facts
Product
Gating events
wikidata
wikipedia
Founded
Key product
FDA clearance
Data & sources
Press releases
2
News coverage
1
Patent documents
5
Web sources
1
9 sources backing this record.View all →
Models (1)
View all models →CMR Surgical on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jan 2022. Explore where CMR Surgical's robots are operating, by place and type.
View the full CMR Surgical deployment record →
Relationships
Explainers
Plain-language answers to the questions people ask about CMR Surgical, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.
What is a surgical robot?
What is CMR Versius?
Current leadership (4)
- Massimiliano Colella CEOIR-verified
- Mark Slack Co-founder & Chief Medical OfficerIR-verified
- Luke Hares Co-founder & Chief Innovation Officer, Chief Innovation Officer & Co-founderIR-verified
- Martin Frost Co-founder & former CEOreported, not verified
Founders (3)
- Mark Slackcofounderfounded 2014-01-01
- Luke Harescofounderfounded 2014-01-01
- Martin Frostcofounderno longer at company
Safety record
1 recall and 4 incidents on record (1 serious, 1 moderate, 3 minor). Most recent: Jul 2026.
Most recent: Jul 2026
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting CMR Surgical (5)
- FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures2026-07-01 · Regulatory action
- CMR Surgical Versius Plus receives FDA 510(k) clearance for gallbladder surgery2026-03-15 · Regulatory action
- FDA clears CMR Surgical Versius Plus surgical robotic platform for cholecystectomy (510(k))2025-12-17 · Regulatory action
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- CMR Surgical2 deployments
Recent coverage
CMR Surgical in third-party press
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Supplied by (1)
Compute / semiconductor
- NVIDIAvia VersiusNVIDIA IGX Thor industrial AI compute platform -- adopted as early-adopter evaluation for next-generation Versius surgical robotic system; IGX Thor delivers up to 5,581 FP4 TFLOPS AI compute with 400 GBe connectivity for real-time surgical AI inference and decision support; CMR Surgical also contributed anonymized surgical data to NVIDIA Isaac GRooT-H vision-language-action model for healthcare roboticssuppliesannounced
Inbound supply edges feeding this company directly or via the models it owns. Same source bar as the outbound view (verified against at least two strong sources).
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships (2)
- CMR Surgical x NVIDIA intelligent surgery with NVIDIAtechnology
- CMR Surgical x NVIDIA Surgical Robot Training with NVIDIAtechnology
Funding rounds (2)
CMR Surgical’s 2 disclosed rounds, $840M in total, oldest to newest.
- Series D2021-06-01
$600M(reported)
Investors: SoftBank Vision Fund 2 (lead)
- Series C2019-09-01
$240M(reported)
Investors: SoftBank Vision Fund 1 (lead)
Regulatory filings (2)
- fda_de_novofda de novo · us_fdacleared2024-10-01
Linked models: Versius
- DEN230078fda de novo · us_fdagranted2023-11-21reported
Linked models: Versius
Patent estate (5)
- US10206752B2usptograntedgranted 2019-02-19assignee
- US10219867B2usptograntedgranted 2019-03-05assignee
- EP2951743B1epograntedgranted 2019-06-26assignee
- US11595242B2usptograntedgranted 2023-02-28assignee
- US20170181802A1usptopendingassignee
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Incident recordedJul 1, 2026
FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal...
- Incident recordedJun 9, 2026
CMR Surgical recalls Versius Surgical System consoles due to Secure Boot cybersecurity...
- Verified media addedVerifiedJun 5, 2026
CMR Versius Plus
- Verified media addedVerifiedJun 5, 2026
Versius robotic cholecystectomy
- Verified media addedVerifiedJun 4, 2026
Introducing Versius
Sources (4)
- https://www.globenewswire.com/news-release/2024/10/15/cmr-surgical-versius-fda-de-novo
- https://www.therobotreport.com/cmr-surgical-receives-fda-clearance-for-versius-plus-surgical-robot/
- https://www.massdevice.com/cmr-surgical-200-million-funding/
- https://www.globenewswire.com/news-release/2026/03/17/cmr-surgical-nvidia-igx-thor
Common questions
What is CMR Surgical?
What does CMR Surgical make?
Is CMR Surgical publicly traded?
Who competes with CMR Surgical?
Who is the CEO of CMR Surgical?
How can I invest in CMR Surgical?
Where is CMR Surgical headquartered?
Who owns CMR Surgical?
Where does CMR Surgical operate robots?
How many robots has CMR Surgical deployed?
Is CMR Surgical a top robotics company?
Are there any incidents involving CMR Surgical?
Is CMR Surgical safe?
Methodology: Claimed (not regulatorily cleared) · 4 sources (2 primary) · last reviewed 2026-08-05
Verification posture
Claimed (not regulatorily cleared)
Cap-flag required
Review state
Drift-flagged
Last reviewed 2026-08-05
1 anchored drift pattern(s); see cap_flags
Sources by quality tier
- 2
- primary-company-ir
- Company IR disclosure
- 1
- secondary-trade-publication
- Trade publication
- 1
- unclassified
- Unclassified source
Cap flags
Claim: CMR Surgical Versius is fully US-pending FDA
Honest status: Versius has De Novo authorization (October 2024, cholecystectomy) and Versius Plus 510(k) clearance (December 2025). Only gynecology 510(k) is currently pending. The wholesale-pending framing is aggregator drift.
Versius is partially US-cleared: De Novo Oct 2024 (cholecystectomy) + Versius Plus 510(k) Dec 2025. Only gynecology 510(k) currently pending.
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for CMR Surgical.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
In the press
Recent coverage mentioning CMR Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.
SRS 2026 recap: The biggest surgical robot stories of the last week
MassDevice recaps SRS 2026: Johnson & Johnson won FDA de novo authorization for the Ottava surgical robot covering multiple general surgery procedures; Medtronic unveiled the…
CMR Surgical and NVIDIA showcase future of intelligent surgery with Versius Plus at SRS 2026
CMR Surgical and NVIDIA showcased the future of intelligent surgery with the Versius Plus robotic surgical system at the Society of Robotic Surgery (SRS) 2026 conference,…
CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plus into Gynecology
CMR Surgical submitted a 510(k) application to the U.S. FDA seeking clearance to expand the Versius Plus robotic surgical system into gynecological procedures, building on its…
CMR Surgical, Nvidia showcase predictive surgical robotic capabilities
CMR Surgical demonstrated its Versius Plus surgical robot using NVIDIA's Isaac for Healthcare simulation to predict surgical environment evolution, making CMR the largest…
CMR Surgical secures 510k clearance of Versius Plus robotic surgical system
CMR Surgical received FDA 510k clearance for its second-generation Versius Plus surgical robot for cholecystectomy procedures, paving the way for US commercial launch in 2026.…
FDA clears CMR Surgical's Versius Plus robot
CMR Surgical secured FDA 510(k) clearance for Versius Plus robotic surgical system for gallbladder removal, priming US commercialization in 2026.
FDA Clears New Robotic Platform for Gallbladder Surgery
CMR Surgicals Versius Plus received FDA 510(k) clearance for gallbladder surgery, on track for US commercialization in 2026.
CMR Raises 00M in Series D Funding for Versius Surgical Robots
CMR Surgical raised 00M in Series D funding to scale Versius, its minimally invasive surgical robot system.
Machine-readable surfaces
- Markdown mirror: /companies/cmr-surgical.md
- RSS feed: /companies/cmr-surgical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/6bbb447e-0278-4ae1-822d-8b546420511e
- Revision history: /companies/cmr-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Video
Transforming Surgery. For Good. The Versius® Surgical Robotic System is CE marked according to EC Directive 93/42/EEC (the MDD) and is intended to assist in th
Our Chief Medical Officer, Mark Slack on how Versius is transforming surgery. Transforming Surgery. For Good. cmrsurgical.com Connect with us: Twitter: http
► Subscribe to Our Channel Here https://www.youtube.com/MullingsGroup --------------- LinkedIn: http://www.linkedin.com/company/the-m... Website: http:/
Watch Professor David Jayne, Consultant Colorectal Surgeon at Leeds General Infirmary provide an insight to the Versius surgical robotic system and its applicat
Experience the live demonstration at Arab Health 2023, an extraordinary event presented by Robotics Surgical Systems! Join us as we showcase the future of surgi
Luke Hares, the visionary behind the Versius surgical robotic system, talks about the key to the Versius design - the human arm - and how Versius' unique design
John Acker (CMR Surgical) discusses advances in the new laparoscopic robotic surgery platform - CMR Surgical. Talk given at the 1st annual symposium for the Hou
What if access to robotic surgery was no longer limited by space, cost or constraints? Versius Plus™ is designed to move with you - unlocking access to the pati
Reality vs attention
CMR Surgical draws attention at the 85th percentile but verifies reality at the 70th percentile among surgical robots. Hype Gap +14.7, 15th widest among surgical robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Thin IP estate relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 17, 2026